urethral stricture in Females is relatively rare disease. So, the management has been inadequately evaluated, with small number of cases and various definitions of success. urethral dilatation was conventionally used as the first line of treatment with low success rates ranging from only 14 to 49%. recently, there has been increasing use of urethroplasty due to the improved success rate. In this study we evaluated the surgical and functional outcomes of anterior on lay buccal mucosal grafts in female urethral stricture.

In our study we prospectively evaluated 25 female patients treated from January 2022 to December 2025 at our center; ages ranged from 24 to 55 years.  anterior on lay buccal mucosal graft urethroplasty was done in all cases. Patients were followed up at 3,6,9 month postoperative clinically with the voiding symptoms, uroflowmetry and post-void residual urine. Failure was defined as persistent of symptoms, no improvement of the urine flow rate and significant amount of post-void residual urine.

The overall Success rate of our approach was 95%. Stricture location was confined to the distal third of urethra in 29%, the mid-urethra in 14%, reach over the distal mid-urethra in 57%. Mean stricture length was 1.8 (0.7–2.1) cm. Mean pre- versus postoperative Qmax was 7 ml/s versus 25.3 ml/s and mean residual urine was 165 ml versus 18 ml. 1 patient had stricture recurrence at 6 months post-operative.

Anterior on lay buccal mucosal graft was found as suitable approach for the management of female urethral stricture with an excellent surgical and functional outcome.